Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.
Hinze, CH; Foell, D; Johnson, AL; Spalding, SJ; Gottlieb, BS; Morris, PW; Kimura, Y; Onel, K; Li, SC; Grom, AA; et al.
Arthritis and Rheumatology.
2019;
71:451-459.
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease.
Lovell, DJ; Johnson, AL; Huang, B; Gottlieb, BS; Morris, PW; Kimura, Y; Onel, K; Li, SC; Grom, AA; Taylor, J; et al.
Arthritis and Rheumatology.
2018;
70:1508-1518.
Barriers to Adherence in Juvenile Idiopathic Arthritis: A Multicenter Collaborative Experience and Preliminary Results.
Favier, LA; Taylor, J; Rich, KL; Jones, KB; Vora, SS; Harris, JG; Gottlieb, BS; Robbins, L; Lai, JT; Lee, T; et al.
Journal of Rheumatology.
2018;
45:690-696.
Lack of Concordance in Interrater Scoring of the Provider's Global Assessment of Children With Juvenile Idiopathic Arthritis With Low Disease Activity.
Taylor, J; Giannini, EH; Lovell, DJ; Huang, B; Morgan, EM.
Arthritis Care and Research.
2018;
70:162-166.
Design and implementation of a decision aid for juvenile idiopathic arthritis medication choices.
Brinkman, WB; Lipstein, EA; Taylor, J; Schoettker, PJ; Naylor, K; Jones, K; Vora, SS; Mims, CC; Roth-Wojcicki, E; Gottlieb, B; et al.
Pediatric Rheumatology.
2017;
15.